InvestorsObserver
×
News Home

Should Biotechnology Stock Tango Therapeutics Inc (TNGX) Be in Your Portfolio Monday?

Monday, November 13, 2023 10:41 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Tango Therapeutics Inc (TNGX) Be in Your Portfolio Monday?

Tango Therapeutics Inc (TNGX) is near the top in its industry group according to InvestorsObserver. TNGX gets an overall rating of 80. That means it scores higher than 80 percent of stocks. Tango Therapeutics Inc gets a 96 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.

Overall Score - 80
TNGX has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on TNGX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 80 means the stock is more attractive than 80 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Tango Therapeutics Inc Stock Today?

Tango Therapeutics Inc (TNGX) stock is trading at $7.57 as of 10:25 AM on Monday, Nov 13, a decline of -$0.79, or -9.45% from the previous closing price of $8.36. The stock has traded between $7.49 and $8.27 so far today. Volume today is low. So far 72,553 shares have traded compared to average volume of 1,648,564 shares. Click Here to get the full Stock Report for Tango Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App